Back to News
Market Impact: 0.42

SpaceX Stock's Biggest Test Isn't Its Post-IPO Drop. It's Coming in Late July.

IPOs & SPACsCorporate EarningsCompany FundamentalsInsider TransactionsInvestor Sentiment & PositioningArtificial IntelligenceTechnology & InnovationM&A & Restructuring

SpaceX's first earnings report is expected in late July or early August, coinciding with a staggered lockup that could make an additional 20% of insiders' shares sellable, plus another tranche if the stock stays 30% above the $135 IPO price. The company disclosed about $18.7 billion in 2025 revenue, a $4.9 billion net loss, $11.4 billion of Starlink revenue, and more than $6 billion in AI-related losses after absorbing xAI; it also agreed to a $60 billion all-stock acquisition of Anysphere. The article argues the combination of a thin float, new supply, and continued losses makes the stock vulnerable despite Starlink's profitability and growth.

Analysis

The first-order setup is a classic post-IPO supply shock, but the more important second-order effect is who gets forced to provide liquidity. With only a very thin free float, even modest insider monetization can overwhelm marginal demand and widen spreads; that tends to punish late IPO buyers first and often pulls down implied sentiment across adjacent high-beta growth names as allocators de-risk. The critical point is that the market has likely been trading the story, not the cash flow, so the first earnings print is the first catalyst that can break narrative-driven ownership.

The business mix matters because the market is implicitly valuing a high-margin connectivity layer and optionality on launch/AI, while the reported economics still appear dominated by one profitable segment offset by capital-intensive losses elsewhere. That creates a fragility where any disappointment on subscriber adds, margins, or capex cadence can compress multiple turns quickly, especially because there is no long history of public guidance to anchor expectations. Conversely, if the report shows Starlink compounding cleanly and cash burn moderating, the stock could re-rate higher despite insider supply, but that would likely be a slower grind rather than a squeeze.

The contrarian read is that the near-term overhang may be less about valuation in absolute terms and more about timing: the market may be underestimating how much supply can hit once the first tranche unlocks versus how little incremental demand exists at these prices. The biggest risk to the short case is that the lockup structure plus a strong first report creates a “good news + limited float” feedback loop, trapping shorts and delaying price discovery until later unlocks. So the trade is really about the next 4-8 weeks, not the next 12 months: if the stock cannot absorb the first earnings/lockup window, the path of least resistance is lower.